会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ARYLOXY AMINE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL MODULATORS
    • ARYLOXY AMINE化合物及其作为钠通道调节剂
    • US20140323527A1
    • 2014-10-30
    • US14222854
    • 2014-03-24
    • Bevyn JARROTT
    • Bevyn JARROTT
    • C07C217/58C07D213/68
    • C07C217/58C07C217/16C07C217/18C07C217/20C07D213/68C07D231/22
    • The present invention relates generally to the field of therapeutic treatment and compounds having utility therefor, in particular the therapy or management of conditions associated with excessive, unwanted or undesirable sodium ion passage through cellular membranes via voltage-gated sodium channels. In one embodiment the invention is concerned with the treatment of neuropathic pain. The invention contemplates to aryloxy-substituted amines, as sodium channel blockers or modulators. In further embodiments, the invention also relates to compounds which may advantageously have dual sodium channel blocker/modulating and antioxidative (free-radical scavenging) effects. Methods for their manufacture and compositions containing the compounds are also contemplated.
    • 本发明一般涉及治疗性治疗领域和其用途的化合物,特别是治疗或管理与通过电压门控钠通道通过细胞膜的过量,不期望或不期望的钠离子相关的病症。 在一个实施方案中,本发明涉及神经性疼痛的治疗。 本发明考虑到作为钠通道阻断剂或调节剂的芳氧基取代的胺。 在另外的实施方案中,本发明还涉及可有利地具有双钠通道阻断剂/调节和抗氧化(自由基清除)作用的化合物。 也考虑了其制造方法和含有这些化合物的组合物。
    • 7. 发明申请
    • Male Contraceptive
    • 男性避孕药
    • US20100029624A1
    • 2010-02-04
    • US12504287
    • 2009-07-16
    • Nnaemeka Ikechukwu AMOBIIan Christopher SMITH
    • Nnaemeka Ikechukwu AMOBIIan Christopher SMITH
    • A61K31/5415A61K31/473A61K31/472A61K31/47A61K31/445A61K31/4402A61K31/40A61K31/136A61P15/00
    • C07C211/27C07C211/45C07C217/16C07C2603/26C07D207/09C07D209/08C07D211/12C07D211/14C07D211/26C07D215/06C07D215/12C07D217/10C07D221/04C07D279/26C07D279/28C07D295/03C07D401/06C07D417/06
    • A compound having formula I. R1, R2, R3 and R4 are independently H or lower alkyl. R5 is aryl, heteroaryl, cycloalkyl, heterocycloalkyl, aryloxy, heteroaryloxy, cycloalkyloxy, heterocycloalkyloxy, arylamino, heteroarylamino, cycloalkylamino, heterocycloalkyl amino, arylthio, heteroarylthio, cycloalkylthio, heterocycloalkylthio, or cyclic olefin, any of which may be substituted or non-substituted; or substituted alkyl, substituted alkyl oxy or substituted alkyl amino wherein the substituent is an aryl, a heteroaryl, a cycloalkyl, a heterocycloalkyl or a cyclic olefin, any of which may be substituted or non-substituted. X is C or N. n and p are independently whole numbers selected from 0, 1 and 2. (CH2)n and (CH2)p may be substituted or non-substituted. Ar1 and Ar2 are independently aryl or heteroaryl groups which may be substituted or non-substituted. Certain specific compounds are excluded.The compounds can be used in a medicament or a method for the reduction or prevention of the emission of sperm, or for the reduction or prevention of transmission of viral agents transmitted in seminal fluid.
    • 具有式I的化合物.R 1,R 2,R 3和R 4独立地为H或低级烷基。 R5是芳基,杂芳基,环烷基,杂环烷基,芳氧基,杂芳氧基,环烷氧基,杂环烷氧基,芳基氨基,杂芳基氨基,环烷基氨基,杂环烷基氨基,芳硫基,杂芳硫基,环烷硫基,杂环烷硫基或环烯烃,其中任何一个可以是取代或未取代的; 或取代的烷基,取代的烷基氧基或取代的烷基氨基,其中取代基是芳基,杂芳基,环烷基,杂环烷基或环烯烃,其中任何一个可以被取代或未取代。 X是C或N.n,p独立地是选自0,1和2的整数。(CH 2)n和(CH 2)p可以是取代或未取代的。 Ar 1和Ar 2独立地为可被取代或未取代的芳基或杂芳基。 排除某些具体化合物。 这些化合物可以用于减少或预防精子发射的药物或方法,或用于减少或防止在精液中传播的病毒剂的传播。